Article

Individualized Prognostic Score for Lung Adenocarcinoma Based on Immune Status

2022-02-01

Abstract excerpt

<h4>Background: </h4> Lung adenocarcinoma (LUAD) is the prevalent non-small cell lung cancer (NSCLC) histological subtype, with rising morbidity and mortality. This study was conducted with the motive to develop a prognostic model by examining the relation between immune-related gene (IRGs) profiles. <h4>Methods: </h4>: We combined immune-related gene (IRG) expression profiles and progression-free intervals (PFIs)...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b1c50c6d-2be8-5881-bc56-df1424afb136
DOI: 10.21203/rs.3.rs-1258129/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Individualized Prognostic Score for Lung Adenocarcinoma Based on Immune StatusDOI 10.21203/rs.3.rs-1258129/v1Read

Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinomaSemantic proximity Read

A new immune signature for survival prediction and immune checkpoint molecules in lung adenocarcinoma.Semantic proximity Read

Exploration of the prognostic signature reflecting tumor microenvironment of lung adenocarcinoma based on immunologically relevant genesSemantic proximity Read

IRGS: an immune-related gene classifier for lung adenocarcinoma prognosisSemantic proximity Read

An immune gene signature to predict prognosis and immunotherapeutic response in lung adenocarcinomaSemantic proximity Read

An Immune Gene Signature for Prediction of Overall Survival and Response to Immune Checkpoint Inhibitors Therapy in Patients with Lung AdenocarcinomaSemantic proximity Read

Identification of an immune-related genes signature in lung adenocarcinoma to predict survival and response to immune checkpoint inhibitorsSemantic proximity Read

Identification of an immune-related genes signature in lung adenocarcinoma to predict survival and response to immune checkpoint inhibitors.Semantic proximity Read

Development and validation of an immune‐related prognostic signature in lung adenocarcinomaSemantic proximity Read

Construction of the optimization prognostic model based on differentially expressed immune genes of lung adenocarcinomaSemantic proximity Read

Development of an Immune-Related Gene Pairs Signature for Predicting Clinical Outcome in Lung AdenocarcinomaSemantic proximity Read

Identification and validation of immune-related lncRNA prognostic signature for lung cancerSemantic proximity Read